A STUDY TO EVALUATE THE ROLE OF PROPHYLACTIC OCTREOTIDE IN PREVENTING ERCP INDUCED PANCREATITIS
Phase 3
- Conditions
- Health Condition 1: null- PATIENTS UNDERGOING ERCP PROCEDURE
- Registration Number
- CTRI/2016/10/007335
- Lead Sponsor
- SETH GS MEDICAL COLLEGE AND KEM HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 113
Inclusion Criteria
1. WILLING TO PARTICIPATE IN THE STUDY
2. UNDERGOING ERCP FOR A VALID INDICATION
3. FOLOOWING UP WITH POST ERCP EVALUATION FOR DIAGNOSING PANCREATITIS
Exclusion Criteria
1. PREGNANCY AND LACTATION
2. CHRONIC RENAL FAILURE
3. ACUTE MYOCARDIAL INFARCTION DURING THE LAST 3 MONTHS BEFORE PROCEDURE
4. HIV POSITIVE OR ANY OTHER IMMUNO-COMPROMISED STATE
5. PLANNED BILIARY STENT REMOVAL OR EXCHANGE
6. HISTORY OF ALCOHOL OR OTHER DRUG ABUSE
7.RECENT USE OF NARCOTIC ANALGESIC OR ANTICHOLINERGIC MEDICATION
8. HISTORY OF CHRONIC PANCREATITIS OR OTHER DISEASE KNOWN TO EFFECT PANCREATIC SECRETION (VAGOTOMY, GASTRECTOMY, INFLAMMATION)
9. REFUSAL TO PARTICIPATE
10. PATIENTS WITH PREVIOUS HISTORY OF ERCP INDUCED PANCREATITIS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method % WITH ERCP INDUCED PANCREATITIS ACCORDING TO THE MODIFIED ATLANTA CLASSIFICATIONTimepoint: 48 HOURS THOUGH . The length of hospital stay will be decided by the treating unit under which the patient is admitted. In case, the patient is discharged before 48 hours, he or she will be followed on a telephonic interview basis.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI